Cargando…

Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis

Advances in medicine and health policy have resulted in growing of older population, with a concurrent rise in multimorbidity, particularly in Iran, as a country transitioning to a western lifestyle, and in which the percent of the population over the age of 60 years is increasing. This study aims t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Batoul, Alimohammadian, Masoomeh, Yaseri, Mehdi, Majidi, Azam, Boreiri, Majid, Islami, Farhad, Poustchi, Hossein, Derakhshan, Mohammad H., Feizesani, Akabar, Pourshams, Akram, Abnet, Christian C., Brennan, Paul, Dawsey, Sanford M., Kamangar, Farin, Boffetta, Paolo, Sadjadi, Alireza, Malekzadeh, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998618/
https://www.ncbi.nlm.nih.gov/pubmed/26886618
http://dx.doi.org/10.1097/MD.0000000000002756
_version_ 1782449973581840384
author Ahmadi, Batoul
Alimohammadian, Masoomeh
Yaseri, Mehdi
Majidi, Azam
Boreiri, Majid
Islami, Farhad
Poustchi, Hossein
Derakhshan, Mohammad H.
Feizesani, Akabar
Pourshams, Akram
Abnet, Christian C.
Brennan, Paul
Dawsey, Sanford M.
Kamangar, Farin
Boffetta, Paolo
Sadjadi, Alireza
Malekzadeh, Reza
author_facet Ahmadi, Batoul
Alimohammadian, Masoomeh
Yaseri, Mehdi
Majidi, Azam
Boreiri, Majid
Islami, Farhad
Poustchi, Hossein
Derakhshan, Mohammad H.
Feizesani, Akabar
Pourshams, Akram
Abnet, Christian C.
Brennan, Paul
Dawsey, Sanford M.
Kamangar, Farin
Boffetta, Paolo
Sadjadi, Alireza
Malekzadeh, Reza
author_sort Ahmadi, Batoul
collection PubMed
description Advances in medicine and health policy have resulted in growing of older population, with a concurrent rise in multimorbidity, particularly in Iran, as a country transitioning to a western lifestyle, and in which the percent of the population over the age of 60 years is increasing. This study aims to assess multimorbidity and the associated risk factors in Iran. We used data from 50,045 participants (age 40–75 y) in the Golestan Cohort Study, including data on demographics, lifestyle habits, socioeconomic status, and anthropometric indices. Multimorbidity was defined as the presence of 2 or more out of 8 self-reported chronic conditions, including cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, chronic kidney disease, liver disease, gastroesophageal reflux disease, tuberculosis, and cancer. Multivariate logistic regression models were used to examine the associations between multiple different factors and the risk factors. Multimorbidity prevalence was 19.4%, with the most common chronic diseases being gastroesophageal reflux disease (76.7%), cardiovascular diseases (72.7%), diabetes (25.3%), and chronic obstructive pulmonary disease (21.9%). The odds of multimorbidity was 2.56-fold higher at the age of >60 years compared with that at <50 years (P < 0.001), and 2.11-fold higher in women than in men (P < 0.001). Other factors associated with higher risk of multimorbidity included non-Turkmen ethnicity, low education, unemployment, low socioeconomic status, physical inactivity, overweight, obesity, former smoking, opium and alcohol use, and poor oral health. Apart from advanced age and female sex, the most important potentially modifiable lifestyle factors, including excess body weight and opium use, and opium user, are associated with multimorbidity. Policies aiming at controlling multimorbidity will require a multidimensional approach to reduce modifiable risk factors in the younger population in developing countries alongside adopting efficient strategies to improve life quality in the older population.
format Online
Article
Text
id pubmed-4998618
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49986182016-09-06 Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis Ahmadi, Batoul Alimohammadian, Masoomeh Yaseri, Mehdi Majidi, Azam Boreiri, Majid Islami, Farhad Poustchi, Hossein Derakhshan, Mohammad H. Feizesani, Akabar Pourshams, Akram Abnet, Christian C. Brennan, Paul Dawsey, Sanford M. Kamangar, Farin Boffetta, Paolo Sadjadi, Alireza Malekzadeh, Reza Medicine (Baltimore) 4400 Advances in medicine and health policy have resulted in growing of older population, with a concurrent rise in multimorbidity, particularly in Iran, as a country transitioning to a western lifestyle, and in which the percent of the population over the age of 60 years is increasing. This study aims to assess multimorbidity and the associated risk factors in Iran. We used data from 50,045 participants (age 40–75 y) in the Golestan Cohort Study, including data on demographics, lifestyle habits, socioeconomic status, and anthropometric indices. Multimorbidity was defined as the presence of 2 or more out of 8 self-reported chronic conditions, including cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, chronic kidney disease, liver disease, gastroesophageal reflux disease, tuberculosis, and cancer. Multivariate logistic regression models were used to examine the associations between multiple different factors and the risk factors. Multimorbidity prevalence was 19.4%, with the most common chronic diseases being gastroesophageal reflux disease (76.7%), cardiovascular diseases (72.7%), diabetes (25.3%), and chronic obstructive pulmonary disease (21.9%). The odds of multimorbidity was 2.56-fold higher at the age of >60 years compared with that at <50 years (P < 0.001), and 2.11-fold higher in women than in men (P < 0.001). Other factors associated with higher risk of multimorbidity included non-Turkmen ethnicity, low education, unemployment, low socioeconomic status, physical inactivity, overweight, obesity, former smoking, opium and alcohol use, and poor oral health. Apart from advanced age and female sex, the most important potentially modifiable lifestyle factors, including excess body weight and opium use, and opium user, are associated with multimorbidity. Policies aiming at controlling multimorbidity will require a multidimensional approach to reduce modifiable risk factors in the younger population in developing countries alongside adopting efficient strategies to improve life quality in the older population. Wolters Kluwer Health 2016-02-18 /pmc/articles/PMC4998618/ /pubmed/26886618 http://dx.doi.org/10.1097/MD.0000000000002756 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4400
Ahmadi, Batoul
Alimohammadian, Masoomeh
Yaseri, Mehdi
Majidi, Azam
Boreiri, Majid
Islami, Farhad
Poustchi, Hossein
Derakhshan, Mohammad H.
Feizesani, Akabar
Pourshams, Akram
Abnet, Christian C.
Brennan, Paul
Dawsey, Sanford M.
Kamangar, Farin
Boffetta, Paolo
Sadjadi, Alireza
Malekzadeh, Reza
Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis
title Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis
title_full Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis
title_fullStr Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis
title_full_unstemmed Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis
title_short Multimorbidity: Epidemiology and Risk Factors in the Golestan Cohort Study, Iran: A Cross-Sectional Analysis
title_sort multimorbidity: epidemiology and risk factors in the golestan cohort study, iran: a cross-sectional analysis
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998618/
https://www.ncbi.nlm.nih.gov/pubmed/26886618
http://dx.doi.org/10.1097/MD.0000000000002756
work_keys_str_mv AT ahmadibatoul multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT alimohammadianmasoomeh multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT yaserimehdi multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT majidiazam multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT boreirimajid multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT islamifarhad multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT poustchihossein multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT derakhshanmohammadh multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT feizesaniakabar multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT pourshamsakram multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT abnetchristianc multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT brennanpaul multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT dawseysanfordm multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT kamangarfarin multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT boffettapaolo multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT sadjadialireza multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis
AT malekzadehreza multimorbidityepidemiologyandriskfactorsinthegolestancohortstudyiranacrosssectionalanalysis